The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final clinical and molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion: NCT00626990.
 
Martin Van Den Bent
Consulting or Advisory Role - Anheart Therapeutics; Boehringer Ingelheim; chimerix; Fore Biotherapeutics; Genenta Science; Incyte; Mundipharma; Nuvation Bio; Servier
Travel, Accommodations, Expenses - Servier
 
Sara Erridge
Consulting or Advisory Role - SERVIER
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Michael Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus; SERVIER
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patent for drug delivery devices, assigned to Moffitt Cancer Center.; Patents for drug delivery devices for the brain
 
Anna Nowak
Consulting or Advisory Role - AstraZeneca; Douglas Pharmaceuticals
Research Funding - AstraZeneca (Inst)
 
Marc Sanson
Honoraria - Novocure; SERVIER
Consulting or Advisory Role - Genenta Science
Research Funding - Owkin (Inst)
 
Alba Brandes
No Relationships to Disclose
 
Wolfgang Wick
Consulting or Advisory Role - GlaxoSmithKline; Roche/Genentech (Inst); SERVIER
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Paul Clement
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai/MSD (Inst); LEO Pharma (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD Belgium BVBA (Inst); Novocure (Inst); Rakuten Medical (Inst); Servier (Inst)
Research Funding - AstraZeneca (Inst)
 
Jean-Francois Baurain
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi/Regeneron (Inst); Sun Pharma (Inst); Sun Pharma (Inst)
 
Warren Mason
Honoraria - Novocure; Servier
Consulting or Advisory Role - Novocure; Ono Pharmaceutical
 
Helen Wheeler
No Relationships to Disclose
 
Michael Weller
Honoraria - Bayer; Novocure
Consulting or Advisory Role - AstraZeneca (I); Bayer (I); Biodexa (I); Curevac; Janssen (I); LEO Pharma (I); Medac; Medac (I); Novartis; Novartis; Novartis (I); Orbus Therapeutics; Pfizer (I); Philogen; Roche (I); Sandoz; Seagen (I); Seagen (I); Servier; Servier (I)
Research Funding - BMS (Inst); Novartis (Inst); Quercegen Pharmaceuticals (Inst); Versameb (Inst)
 
Kenneth Aldape
Patents, Royalties, Other Intellectual Property - DNA methylation-based cancer diagnostics for tumors of the central nervous system, kidney and hematopoietic system; Predicting DNA methylation and tumor types from histopathology
 
Pieter Wesseling
Consulting or Advisory Role - Alexion Pharmaceuticals
Expert Testimony - Chimerix
 
Johan Kros
No Relationships to Disclose
 
Mircea Tesileanu
No Relationships to Disclose
 
Golfinopoulos Vassilis
No Relationships to Disclose
 
Thierry Gorlia
No Relationships to Disclose
 
Pim French
Employment - Bristol-Myers Squibb (I); Janssen-Cilag (I)
Honoraria - SERVIER
Consulting or Advisory Role - Clarionhealthcare
 
Brigitta Baumert
Honoraria - Roche
Consulting or Advisory Role - Noxxon Pharma; Roche/Genentech
Travel, Accommodations, Expenses - Noxxon Pharma; Roche
(OPTIONAL) Uncompensated Relationships - SAKK (Swiss Group for Clinical Cancer Research); SASRO (Scientific Association of Swiss Radiation -Oncology)
 
EORTC Brain Tumor Group
No Relationships to Disclose